Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Hemorrhagic Transformation in Alteplase-Treated Stroke
NCT06653946Phase 4Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in ischemic stroke, sponsored by Kafrelsheikh University. Started Jul 2022; status: recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06653946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653946.